For example, in a study on the potential of E-FABP as a biomarker for cervical cancer, the relationship between E-FABP expression level and cervical cancer has not been clearly explained through which pathway, and the significance of E-FABP expression to the severity and prognosis of cervical cancer has also not been explained in detail [84]. This evidence concerns the gene FABP5 and cervical cancer.